Nitur Medical
Cardio and Respiratory Ultrasound Based Monitor
Company Overview
Snapshot
Founded in January 2024, Nitur Medical operates with 1–10 employees. The company has secured funding across one round from eHealth Ventures, and is currently in the Pre-Seed stage. In April 2024, Nitur Medical received funding from eHealth Ventures.
Business overview
Nitur Medical is developing COPatch, a flexible patch equipped with ultrasound micro-transducers designed for continuous and accurate hemodynamic data monitoring. The device, placed on a patient’s chest, processes ultrasound signals using AI to provide precise continuous cardiac output parameters. The company operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Diagnostics Devices, and leverages Artificial Intelligence to serve the Healthcare & Life Sciences market, targeting providers.
Company Intelligence Q&A
- What is Nitur Medical's primary focus?
- Nitur Medical is focused on developing a cardio and respiratory ultrasound-based monitor, specifically the COPatch, for continuous and accurate hemodynamic data monitoring.
- When was Nitur Medical founded?
- Nitur Medical was founded in January 2024.
- Which investor participated in Nitur Medical's funding round?
- In April 2024, Nitur Medical secured Pre-Seed funding from eHealth Ventures.
- What technology does Nitur Medical utilize in its product?
- Nitur Medical's COPatch processes ultrasound signals using an AI machine to provide accurate continuous cardiac output parameters.
- What market does Nitur Medical target?
- Nitur Medical targets the Healthcare & Life Sciences market, specifically focusing on healthcare providers with its diagnostic devices.